Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models.

已完结 10 由 TT 发布于 2024/12/28 23:45:11

DOI:10.1172/JCI174249
作者：Dezhi Li,?Ke Geng,?Yuan Hao,?Jiajia Gu,?Saurav Kumar,?Annabel T Olson,?Christina C Kuismi,?Hye Mi Kim,?Yuanwang Pan,?Fiona Sherman,?Asia M Williams,?Yiting Li,?Fei Li,?Ting Chen,?Cassandra Thakurdin,?
文献类型：期刊论文
补充材料：只需要正文

Journal of Clinical Investigation (JCI)

Abstract：KRAS is the most frequently mutated oncogene in lung adenocarcinoma, with G12C and G12V being the most predominant forms. Recent breakthroughs in KRASG12C inhibitors have transformed the cli

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Rice Stripe Mosaic Virus Encoded P6 Interacts with Heading Protein OsHAPL1 to Promote Viral Infection